PreDxion Bio, Inc. – Trademark Portfolio

Entity Type: 03

PreDxion Bio, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REFRACTAL. The owner is based in South San Francisco, CA.

329 Oyster Point Blvd, Floor3

South San Francisco, CA 94080

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PREDXION
PREDXION
Abandoned 2021
REFRACTAL
REFRACTAL
Registered 2021

Trademark Classifications

PreDxion Bio, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does PreDxion Bio, Inc. have?

PreDxion Bio, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does PreDxion Bio, Inc. file in?

PreDxion Bio, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are PreDxion Bio, Inc.'s most well-known trademarks?

PreDxion Bio, Inc.'s registered trademark portfolio includes well-known marks such as REFRACTAL. These are among 1 currently registered trademark in the portfolio.

What is PreDxion Bio, Inc.'s trademark registration success rate?

PreDxion Bio, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.